Acetyl Tetrapeptide-5

We are Acetyl Tetrapeptide-5 CAS:820959-17-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Acetyl Tetrapeptide-5
CAS.NO:820959-17-9
Synonyms:Acetyl Tetrapeptide-5
(2S)-2-[[(2S)-2-[[(2S)-2-(3-acetamidopropanoylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid
N-Acetyl-β-alanyl-L-histidyl-L-seryl-L-histidine
Eyeseryl
Ac-beta-Ala-His-Ser-His
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 1237.3±65.0 °C at 760 mmHg
Molecular Formula C20H28N8O7
Molecular Weight 492.486
Flash Point 702.1±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.611
 
Specification:
Appearance:White Freeze-dried Powder
Purity(HPLC):≥99.0%
Content:≥85.0%
Acetic Acid:≤5%
Moisture:≤8.0%
 
Packing:5 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Especially suitable for eye products, eliminating bags and dark circles, improving skin elasticity and smoothness.
As the age increases, the skin gradually loses its elasticity, muscle function weakens, and the skin around the eyes relaxes and forms pouches. Excessive accumulation of water in the eyelid is eyelid edema. Acetyl tetrapeptide-5 can eliminate edema and improve skin elasticity and smoothness. Collagen cross-linking is also the cause of eye bags. Acetyl tetrapeptide-5 can inhibit saccharification and reduce the effect of eye bags and wrinkles.

Acetyl Tetrapeptide-5


Related News: There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.2,4-dimetil-1H-pirrol-3-carboxilato de etilo CAS:2199-51-1 There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.3-Amino-2-fluoropyridine CAS:1597-33-7 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.9-(4-Bromophenyl)-10-phenylanthracene The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.

Related Products
Product Name
2,6-Difluorobenzyl chloride View Details
3,4,5-Trichlorobenzotrifluoride View Details
4-Bromo-2-trifluoromethoxyaniline View Details
4-Glycidyloxycarbazole manufacturer N(Alpha)-Boc-L-2,3-Diaminopropionic Acid manufacturer 2-methyl-2-(methylsulfanyl)propanaldoxime manufacturer 10-bromo-2-phenyl-9-(4-phenylphenyl)anthracene manufacturer 3-Chloro-4-Fluorotoluene manufacturer